Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Therapy”

1,278 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,278 results

Large-scale testing (Phase 3)Study completedNCT00234910
What this trial is testing

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Who this might be right for
HIV Infection
Abbott 152
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07005583
What this trial is testing

Clinical Study of QL1706 in Combination With Olaparib for the Treatment of Patients With Previously Treated Homologous Recombination Repair-Deficient Recurrent or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
Tianjin Medical University Cancer Institute and Hospital 46
Early research (Phase 1)Ended earlyNCT00972023
What this trial is testing

DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Barbara Ann Karmanos Cancer Institute 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07419880
What this trial is testing

Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer

Who this might be right for
Triple -Negative Breast Cancer
Fudan University 46
Large-scale testing (Phase 3)Looking for participantsNCT06767527
What this trial is testing

AK112 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/ Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
Akeso 416
Not applicableUnknownNCT05699785
What this trial is testing

Comparison of Inflammatory Markers and Incidence of Comorbidities in Patients on Antiretroviral Therapy With Second-generation Anti-integrase Drugs on Triple Versus Dual Therapy

Who this might be right for
Hiv
Centre Hospitalier Universitaire de Nice 500
Large-scale testing (Phase 3)Study completedNCT01505127
What this trial is testing

Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. Pylori

Who this might be right for
H. Pylori Infection
Takeda 650
Early research (Phase 1)Study completedNCT01969643
What this trial is testing

A Safety Study of SGN-LIV1A in Breast Cancer Patients

Who this might be right for
HER2 Positive Breast NeoplasmsHormone Receptor Positive Breast NeoplasmsTriple Negative Breast Neoplasms+1 more
Seagen Inc. 290
Testing effectiveness (Phase 2)Study completedNCT01581138
What this trial is testing

VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C

Who this might be right for
Chronic Hepatitis C Virus
Vertex Pharmaceuticals Incorporated 64
Testing effectiveness (Phase 2)Study completedNCT02834403
What this trial is testing

L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients

Who this might be right for
Metastatic Triple Negative Breast Cancer
The Methodist Hospital Research Institute 37
Post-approval studies (Phase 4)WithdrawnNCT02561117
What this trial is testing

Once Daily Metronidazole for Perforated Appendicitis

Who this might be right for
Appendicitis
Ahmed Nasr
Not applicableStudy completedNCT04184297
What this trial is testing

Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to Triple Therapy

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 27,190
Not applicableEnded earlyNCT02049853
What this trial is testing

The Triple A Initiative Study ("Aktionsbündnis Akute Atemnot")

Who this might be right for
DyspneaHeart Failure
Prof. Dr. Michael Christ 67
Post-approval studies (Phase 4)Looking for participantsNCT07244003
What this trial is testing

Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 430
Testing effectiveness (Phase 2)Study completedNCT00088556
What this trial is testing

Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Telik 100
Not applicableLooking for participantsNCT04510129
What this trial is testing

Cancer Biospecimen Collection Study

Who this might be right for
Cancer of Head and NeckLung Cancer, Nonsmall CellSmall-cell Lung Cancer+8 more
Cofactor Genomics, Inc. 1,650
Not applicableEnded earlyNCT01984866
What this trial is testing

CPR Prediction After Neoadjuvant Using Excisional Biopsy By Radiofrequency In Breast Cancer From II-III UICC Stages.

Who this might be right for
Triple Negative, HER2+, Luminal B Breast Tumors (Stages II-III)in Female Patients
Hospital General Universitario Gregorio Marañon 13
Not applicableUnknownNCT02843672
What this trial is testing

Operative Treatment Of Metatarsalgia: Triple Weil Osteotomy Or Distal Metatarsal Minimal Invasive Osteotomy (DMMO)?

Who this might be right for
Metatarsalgia
Manuel Cuervas-Mons 40
Early research (Phase 1)WithdrawnNCT05650203
What this trial is testing

JS009 Monotherapy and JS009 as a Triple Combination Therapy in Patients With Advanced Malignancies

Who this might be right for
Primary Condition: Advanced Tumors
Shanghai Junshi Bioscience Co., Ltd.
Post-approval studies (Phase 4)Study completedNCT00469183
What this trial is testing

Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma

Who this might be right for
Melasma
Galderma R&D 70
Load More Results